MWZB is pleased to announce the publication of a new book on patent term extension. Patent term extension is a critical factor in protecting the rights of innovator pharmaceutical corporations after expiration of the normal patent term. The text contains sections explaining the applicable law in major markets worldwide where extension is available, including the U.S., EU, Japan, Germany, and more. The chapter on U.S. law was written by MWZB attorneys Brion Heaney and Harry Shubin, who together have nearly 60 years of experience in the prosecution of pharma patents.
Confidential/Privileged Information MWZB is pleased that you would like to contact the firm. However, you should be aware that any information, documents and the like submitted in connection with this email message or otherwise via the firm’s website will not be treated as a privileged or confidential attorney/client communication unless and until the relationship is governed by an engagement letter. You are not a client of MWZB in the absence of such an engagement letter. If you understand and accept these terms and wish to proceed, please enter your email address below.